FAIM
GDRX icon

Financial Advocates Investment Management’s GoodRx Holdings GDRX Stock Holding History

Financial Advocates Investment Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,191
Closed -$1.87M – 760
2021
Q2 		$1.87M Buy
24,191
+5,104
+27% +$188K 0.12% 197
2021
Q1 		$858K Buy
19,087
+10,052
+111% +$452K 0.06% 357
2020
Q4 		$539K Buy
+9,035
New +$415K 0.04% 430

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return

Financial Advocates Investment Management's GDRX Position: Q2 2022 in Review

Financial Advocates Investment Management sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 10,426 shares — an estimated $202K sold.

Financial Advocates Investment Management first reported a position in GDRX in Q3 2021 and held it in 3 quarters. The position peaked at $544K in Q3 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

  • Financial Advocates Investment Management reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
  • Financial Advocates Investment Management sold 10,426 GoodRx Holdings shares in Q2 2022, an estimated $202K.
  • Financial Advocates Investment Management first reported a position in GoodRx Holdings in Q3 2021 and held it in 3 quarters.
  • Financial Advocates Investment Management's GoodRx Holdings position peaked at $544K in Q3 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Financial Advocates Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.